Editor's Note: This article relies on data from the Vaccine Adverse Event Reporting System. It is important to note that this data is based on unverified reports, without cause/effect determination.
______
According to a recent report, a whopping 5,800 Americans have contracted COVID-19 despite being fully vaccinated with either the single-shot Johnson & Johnson, the double-shot Moderna or the double-shot Pfizer vaccine.
The Centers for Disease Control and Prevention told the Epoch Times that of the 5,800 fully vaccinated individuals that contracted the virus, nearly 400 required hospitalization and 74 died.
“To date, no unexpected patterns have been identified in case demographics or vaccine characteristics,” the CDC said.
“COVID-19 vaccines are effective and are a critical tool to bring the pandemic under control. All of the available vaccines have been proven effective at preventing severe illness, hospitalizations, and deaths. However, like is seen with other vaccines, we expect thousands of vaccine breakthrough cases will occur even though the vaccine is working as expected.”
While the CDC has paused the Johnson & Johnson vaccine, the other vaccines actually have higher rates of these reported events. Even if these cases are underreported, one would expect them all to be underreported similarly, so the lower rates in the Johnson & Johnson are likely meaningful.
Here is data sourced from the CDC on clotting/bleeding in the VAERS for the three vaccines:
| Vaccinated (millions) | Thrombocytopenia | Thrombosis | Haemorrhage | Total Fatalities | Tpnia Rate | Thromb Rate | Haem Rate | Mort Rate | |
| J&J | 7.164152 | 4 | 6 | 5 | 42 | 0.56 | 0.84 | 0.70 | 5.86 |
| Moderna | 31.355979 | 41 | 43 | 28 | 1001 | 1.31 | 1.37 | 0.89 | 31.92 |
| Pfizer | 36.76424 | 44 | 66 | 54 | 986 | 1.20 | 1.80 | 1.47 | 26.82 |
To clarify, "rates" are numbers per million of people fully vaccinated (1 dose for J&J, 2 doses for the others).
According to drug regulators, Pfizer’s vaccine is 95 percent effective, Moderna’s is 94.1 percent effective, and Johnson & Johnson’s is 66.9 percent effective.
It is critical to note that the percentage of these vaccine breakthroughs, or infection post-vaccination, depends on multiple factors including vaccine efficacy, the amount of virus circulating and the length of time since inoculation.
While we don’t know much about these vaccines, we do know one thing: what we don’t know can hurt.
